JPMorgan Chase & Co. Has $2.71 Million Stake in Genesis Healthcare, Inc. (NYSE:GEN)
JPMorgan Chase & Co. boosted its stake in shares of Genesis Healthcare, Inc. (NYSE:GEN) by 500.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,026,169 shares of the company’s stock after buying an additional 855,240 shares during the period. JPMorgan Chase & Co. owned approximately 1.11% of Genesis Healthcare worth $2,709,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. Bank of New York Mellon Corp boosted its position in shares of Genesis Healthcare by 2.4% in the first quarter. Bank of New York Mellon Corp now owns 229,770 shares of the company’s stock valued at $607,000 after buying an additional 5,451 shares during the last quarter. Teton Advisors Inc. boosted its position in shares of Genesis Healthcare by 19.0% in the first quarter. Teton Advisors Inc. now owns 50,000 shares of the company’s stock valued at $132,000 after buying an additional 8,000 shares during the last quarter. Teachers Advisors LLC boosted its position in shares of Genesis Healthcare by 51.2% in the fourth quarter. Teachers Advisors LLC now owns 65,810 shares of the company’s stock valued at $280,000 after buying an additional 22,291 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Genesis Healthcare by 9.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 568,706 shares of the company’s stock valued at $2,417,000 after buying an additional 47,744 shares during the last quarter. Finally, State Street Corp boosted its position in shares of Genesis Healthcare by 15.7% in the fourth quarter. State Street Corp now owns 734,589 shares of the company’s stock valued at $3,124,000 after buying an additional 99,474 shares during the last quarter. 14.37% of the stock is currently owned by institutional investors and hedge funds.
Genesis Healthcare, Inc. (GEN) traded down 2.04% during mid-day trading on Monday, hitting $1.44. 276,848 shares of the stock were exchanged. The firm’s market cap is $133.53 million. The company has a 50 day moving average of $1.64 and a 200 day moving average of $2.54. Genesis Healthcare, Inc. has a 12-month low of $1.41 and a 12-month high of $4.75.
Genesis Healthcare (NYSE:GEN) last announced its earnings results on Tuesday, May 9th. The company reported ($0.50) EPS for the quarter, missing the consensus estimate of ($0.25) by $0.25. The company had revenue of $1.39 billion for the quarter, compared to analysts’ expectations of $1.40 billion. Genesis Healthcare had a negative net margin of 1.27% and a negative return on equity of 0.81%. During the same quarter in the previous year, the business posted ($0.48) earnings per share. On average, equities analysts anticipate that Genesis Healthcare, Inc. will post ($1.27) earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This report was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark laws. The legal version of this report can be accessed at https://www.thecerbatgem.com/2017/08/07/genesis-healthcare-inc-nysegen-stake-increased-by-jpmorgan-chase-co-updated-updated-updated.html.
A number of research firms have recently weighed in on GEN. Cantor Fitzgerald began coverage on shares of Genesis Healthcare in a report on Wednesday, July 5th. They issued an “overweight” rating on the stock. ValuEngine cut shares of Genesis Healthcare from a “sell” rating to a “strong sell” rating in a report on Thursday, July 13th. Three analysts have rated the stock with a sell rating, one has issued a hold rating and one has issued a buy rating to the company’s stock. Genesis Healthcare presently has an average rating of “Hold” and an average target price of $2.65.
Genesis Healthcare Company Profile
Genesis Healthcare, Inc is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services.
Receive News & Stock Ratings for Genesis Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare Inc. and related stocks with our FREE daily email newsletter.